A. Fanlo

发表

Influence of the Urine Flow Rate on Some Caffeine Metabolite Ratios Used to Assess CYP1A2 Activity

M. L. Bernal, B. Sinúes, A. Fanlo, 2002, Therapeutic drug monitoring.

CYP2A6 activity in a healthy Spanish population: effect of age, sex, smoking, and oral contraceptives

B. Sinúes, A. Fanlo, E. Mayayo, 2008, Human & experimental toxicology.

Differences between Spaniards and Ecuadorians in CYP2A6 allele frequencies: comparison with other populations

B. Martínez-Jarreta, B. Martinez-Jarreta, Fabricio González-Andrade, 2011, Fundamental & clinical pharmacology.

Growth hormone does not alter CYP2A6 activity in growth hormone-deficient children.

B. Sinúes, A. Fanlo, E. Mayayo, 2007, Basic & clinical pharmacology & toxicology.

Variants of the Solute Carrier SLC16A1 Gene (MCT1) Associated With Metabolic Responses During a Long-Graded Test in Road Cyclists

C. González-Haro, B. Sinúes, A. Fanlo, 2015, Journal of strength and conditioning research.

Five caffeine metabolite ratios to measure tobacco-induced CYP1A2 activity and their relationships with urinary mutagenicity and urine flow.

M. L. Bernal, B. Sinúes, A. Fanlo, 1999, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

Frequency Distribution of C3435T Mutation in Exon 26 of the MDR1 Gene in a Spanish Population

M. L. Bernal, B. Sinúes, A. Fanlo, 2003, Therapeutic drug monitoring.

CYP 3 A 5 * 3 , CYP 3 A 4 * 1 B and MDR 1 C 3435 T genotype distributions in Ecuadorians

B. Martínez-Jarreta, F. González-Andrade, B. Sinúes, 2014 .

Effects of growth hormone deficiency and rhGH replacement therapy on the 6β-hydroxycortisol/free cortisol ratio, a marker of CYP3A activity, in growth hormone-deficient children

M. L. Bernal, B. Sinúes, A. Fanlo, 2004, European Journal of Clinical Pharmacology.

CYP3A5*3 and CYP3A4*1B Allele Distribution and Genotype Combinations: Differences Between Spaniards and Central Americans

B. Martínez-Jarreta, P. Vásquez, B. Sinúes, 2007, Therapeutic drug monitoring.

Lack of effect of growth hormone replacement therapy on CYP1A2 and xanthine oxidase activities in growth hormone–deficient children

B. Sinúes, A. Fanlo, E. Mayayo, 2006, European Journal of Clinical Pharmacology.

Polymorphism C3435T of the MDR1 gene in Central Americans and Spaniards

B. Martínez-Jarreta, P. Vásquez, B. Sinúes, 2008, Molecular Biology Reports.

Haplotype structure and allele frequencies of CYP2B6 in Spaniards and Central Americans

P. Vásquez, B. Sinúes, A. Fanlo, 2009, Fundamental & clinical pharmacology.

MDR-1 C3435T Genetic Polymorphism and Tobacco-Related Lung Cancer

D. Isla, S. Bello, M. L. Bernal, 2003, Oncology.

Genetic polymorphisms of CYP2C8, CYP2C9 and CYP2C19 in Ecuadorian Mestizo and Spaniard populations: a comparative study

B. Martínez-Jarreta, B. Sinúes, A. Fanlo, 2014, Molecular Biology Reports.

Six mutagenicity assays in exposure biomonitoring of patients receiving carbamazepine for epilepsy or trigeminal neuralgia.

J. Gazulla, M. L. Bernal, B. Sinúes, 1995, Mutation research.

Urinary Mutagenicity, CYP1A2 and NAT2 Activity in Textile Industry Workers

B. Martínez-Jarreta, B. Sinúes, A. Fanlo, 2004, Journal of occupational health.

Omeprazole treatment: genotoxicity biomarkers, and potential to induce CYP1A2 activity in humans

B. Sinúes, A. Fanlo, E. Mayayo, 2004, Human & experimental toxicology.

CYP3A5*3, CYP3A4*1B and MDR1 C3435T Genotype Distributions in Ecuadorians

B. Martínez-Jarreta, B. Sinúes, A. Fanlo, 2008, Disease markers.

Haplotype structure and allele frequencies of CYP2B6 in Spaniards and Central Americans

B. Sinúes, A. Fanlo, I. Arenaz, 2009, Fundamental & Clinical Pharmacology.

Genetic polymorphisms of CYP2C8, CYP2C9 and CYP2C19 in Ecuadorian Mestizo and Spaniard populations: a comparative study

B. Martínez-Jarreta, B. Sinúes, A. Fanlo, 2014, Molecular Biology Reports.